BB Biotech AG (BBZA)
XETR
Closed
Aug 25, 2026
Day's Range
59.5052 wk Range
33.40Overview - BBZA - BB Biotech AG
Key Statistics
Valuation
Enterprise Value
178.31M
P/E (Trailing)
‪13.31‬
P/E (Forward)
‪27.07‬
PEG Ratio
‪-0.04‬
Price / Sales (TTM)
‪3.06‬
Price / Book
‪0.98‬
Profitability
Profit Margin
‪127.31%‬
Operating Margin
‪97.74%‬
Return on Assets
‪25.87%‬
Return on Equity
‪54.76%‬
Ownership
Shares Outstanding
55.14M
Held by Insiders
‪0.07%‬
Held by Institutions
‪19.24%‬
Price stats
Beta
‪0.65‬
50-Day Avg
‪33.40‬
200-Day Avg
‪33.40‬
Dividends
Payout Ratio
‪87.34%‬
Frequency
Annual
Market Cap - BBZA - BB Biotech AG
Peers - BBZA - BB Biotech AG
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- BBZAXETRBB Biotech AG3.24BMarket Cap+42.52%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- ANLXETRAnalog Devices, Inc.156.54BMarket Cap+32.98%52-week change44.45P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna, Inc.47.26BMarket Cap+82.35%52-week change-16.82P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE24.12BMarket Cap+7.70%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BV3XETRBavarian Nordic A/S1.81BMarket Cap+6.58%52-week change11.74P/E (Trailing)‪19.70%‬Profit Margin
- AYJXETRValneva SE543.14MMarket Cap-34.01%52-week change70.98P/E (Trailing)‪-110.29%‬Profit Margin
- BSTXETRBastei Lübbe AG85.93MMarket Cap-57.01%52-week change13.50P/E (Trailing)‪5.36%‬Profit Margin
Profile Summary - BBZA - BB Biotech AG
About
BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Founded in 1993 and headquartered in Schaffhausen, it invests primarily in publicly traded companies developing and commercializing innovative drugs that address significant unmet medical needs, such as oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
